Dynavax Technologies
DVAX
#5113
Rank
$1.82 B
Marketcap
$15.50
Share price
0.00%
Change (1 day)
10.64%
Change (1 year)

Dynavax Technologies (DVAX) - Cash on Hand

Cash on Hand as of September 2025 : $0.64 Billion USD

According to Dynavax Technologies 's latest financial reports the company has $0.64 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Dynavax Technologies - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$0.71 B-3.84%
2023-12-31$0.74 B18.88%
2022-12-31$0.62 B14.37%
2021-12-31$0.54 B230.81%
2020-12-31$0.16 B9.26%
2019-12-31$0.15 B3.79%
2018-12-31$0.14 B-24.14%
2017-12-31$0.19 B135.65%
2016-12-31$81.41 M-58.49%
2015-12-31$0.19 B59.9%
2014-12-31$0.12 B-35.23%
2013-12-31$0.18 B51.34%
2012-12-31$0.12 B9.8%
2011-12-31$0.11 B57.94%
2010-12-31$72.15 M96.5%
2009-12-31$36.72 M-46.38%
2008-12-31$68.47 M-22.41%
2007-12-31$88.24 M21.17%
2006-12-31$72.83 M-3.03%
2005-12-31$75.11 M14.07%
2004-12-31$65.84 M126.29%
2003-12-31$29.09 M-1.06%
2002-12-31$29.41 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
$11.69 B 1,705.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$13.98 B 2,059.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$1.28 B 98.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$3.17 B 390.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$7.14 B 1,002.32%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$4.96 B 666.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
$4.11 B 535.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
$18.73 M-97.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$3.65 B 464.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel